(19)

(11)

EP 4 823 546 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24829091.8 (22) Date of filing: 13.12.2024

(51) International Patent Classification (IPC):  A61K 9/08(2006.01) A61K 47/18(2017.01) A61P 25/28(2006.01) A61K 39/395(2006.01) A61K 47/26(2006.01) A61P 9/04(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0019; A61K 9/08; A61K 47/183; A61K 47/26; A61P 25/28; A61P 9/04; C07K 16/18; A61K 39/39591; C07K 2317/34 (86) International application number: PCT/EP2024/086167 (87) International publication number: WO 2025/125544 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.12.2023 EP 23217183 (71) Applicant: Novo Nordisk A/S 2880 Bagsværd (DK)	(72) Inventors: CHRISTOFFERSEN, Stig 2880 Bagsværd (DK) LORENZEN, Nikolai 2880 Bagsværd (DK) ENGELUND, Dorthe Kot 2880 Bagsværd (DK)